Panaxia Labs (Israel) Today
| PNAX Stock | ILA 9,578 1,901 24.76% |
Performance0 of 100
| Odds Of DistressLess than 31
|
Panaxia Labs is trading at 9578.00 as of the 30th of April 2024, a 24.76% increase since the beginning of the trading day. The stock's open price was 7677.0. Panaxia Labs has about a 31 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Panaxia Labs has reported 100 for 1 split on 17th of March 2024. Equity ratings for Panaxia Labs Israel are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of March 2024 and ending today, the 30th of April 2024. Click here to learn more.
Panaxia Pharmaceutical Industries Ltd provides pharmaceutical solutions for patients and physicians. The company was incorporated in 2016 and is based in Lod, Israel. PANAXIA LABS is traded on Tel Aviv Stock Exchange in Israel. The company has 14.97 M outstanding shares. More on Panaxia Labs Israel
Moving against Panaxia Stock
| 0.54 | ELRN | Elron Electronic Ind | PairCorr |
Panaxia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Panaxia Labs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Panaxia Labs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | David Segal |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Panaxia Labs Israel (PNAX) is traded on Tel Aviv Stock Exchange in Israel and employs 130 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 28.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Panaxia Labs's market, we take the total number of its shares issued and multiply it by Panaxia Labs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Panaxia Labs Israel operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 14.97 M outstanding shares.
Panaxia Labs Israel has accumulated about 6.97 M in cash with (47.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check Panaxia Labs Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Panaxia Labs Israel is 28.82 Million. Panaxia Labs holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.66 pct. of Panaxia Labs Israel outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Panaxia Ownership Details
Panaxia Stock Price Odds Analysis
What are Panaxia Labs' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Panaxia Labs jumping above the current price in 90 days from now is about 80.57%. The Panaxia Labs Israel probability density function shows the probability of Panaxia Labs stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Panaxia Labs Israel has a beta of -1.6871 indicating as returns on its benchmark rise, returns on holding Panaxia Labs Israel are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Panaxia Labs is expected to outperform its benchmark. Additionally, panaxia Labs Israel has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Panaxia Labs to move above the current price in 90 days from now is about 80.57 (This Panaxia Labs Israel probability density function shows the probability of Panaxia Stock to fall within a particular range of prices over 90 days) .
Panaxia Labs Israel Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Panaxia Labs market risk premium is the additional return an investor will receive from holding Panaxia Labs long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Panaxia Labs. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Panaxia Labs' alpha and beta are two of the key measurements used to evaluate Panaxia Labs' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.45 | |||
| Standard Deviation | 6.7 | |||
| Variance | 44.95 | |||
| Risk Adjusted Performance | (0.03) |
Panaxia Stock Against Markets
Picking the right benchmark for Panaxia Labs stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Panaxia Labs stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Panaxia Labs is critical whether you are bullish or bearish towards Panaxia Labs Israel at a given time. Please also check how Panaxia Labs' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Panaxia Labs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Panaxia Labs Corporate Management
Elected by the shareholders, the Panaxia Labs' board of directors comprises two types of representatives: Panaxia Labs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Panaxia. The board's role is to monitor Panaxia Labs' management team and ensure that shareholders' interests are well served. Panaxia Labs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Panaxia Labs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Ginossar | Internal Auditor | Profile | |
| Jonathan Kolber | Chairman of the Board | Profile | |
| Assi Rotbart | Chief Business Officer, Director | Profile | |
| Dedi Segal | Founder Director | Profile | |
| Sigal Eli | Chief Officer | Profile | |
| Rinat Gazit | Independent Director | Profile |
How to buy Panaxia Stock?
Before investing in Panaxia Labs, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Panaxia Labs. To buy Panaxia Labs stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Panaxia Labs. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Panaxia Labs stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Panaxia Labs Israel stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Panaxia Labs Israel stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Panaxia Labs Israel, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Panaxia Labs Israel?
The danger of trading Panaxia Labs Israel is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Panaxia Labs is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Panaxia Labs. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Panaxia Labs Israel is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Panaxia Labs Israel. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Panaxia Stock analysis
When running Panaxia Labs' price analysis, check to measure Panaxia Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Panaxia Labs is operating at the current time. Most of Panaxia Labs' value examination focuses on studying past and present price action to predict the probability of Panaxia Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Panaxia Labs' price. Additionally, you may evaluate how the addition of Panaxia Labs to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |